NCT05829252

Brief Summary

The goal of this clinical trial is to test the acceptability, feasibility, accuracy and precision of the 'GrowthMonitor' smartphone app in a pilot population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
146

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 18, 2021

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

March 6, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 25, 2023

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2025

Completed
Last Updated

March 10, 2025

Status Verified

March 1, 2025

Enrollment Period

3.9 years

First QC Date

March 6, 2023

Last Update Submit

March 7, 2025

Conditions

Short StatureGrowth Disorders

Keywords

Height measurementChild heightShort statureSmartphone AppDigital Health

Outcome Measures

Primary Outcomes (2)

  • Reliability

    Inter- and intra-rater reproducibility of the GrowthMonitor app

    At baseline

  • Agreement

    Agreement between the GrowthMonitor app and wall-fixed stadiometer

    At baseline

Secondary Outcomes (1)

  • Usability

    At 1 week

Eligibility Criteria

Age1 Year - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients attending prearranged new and follow-up outpatient appointments at the Children's Hospital at Barts Health Trust, London. Participants will be recruited through convenience sampling in order to maximize recruitment efforts during the time of the study. Data on gender, age, and height will be collected.

You may qualify if:

  • Children and young people (male and female) aged 1-18 yr receiving height measurements as part of their routine / prearranged attendance to a paediatric endocrinology or other paediatric out-patient appointment at Barts Health Trust.
  • Participants require a smartphone to take part in the study.

You may not qualify if:

  • Children under the age of 1 years
  • Young people aged 16-18yr who lack capacity to consent
  • Other individuals unable to reliably stand for an accurate height measurement e.g.
  • individuals with severe disability and/or confined to a wheelchair

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Barts Health NHS Trust

London, United Kingdom

Location

MeSH Terms

Conditions

DwarfismGrowth Disorders

Condition Hierarchy (Ancestors)

Bone Diseases, DevelopmentalBone DiseasesMusculoskeletal DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesEndocrine System DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Helen Storr, PhD

    Queen Mary University, London

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 6, 2023

First Posted

April 25, 2023

Study Start

March 18, 2021

Primary Completion

January 31, 2025

Study Completion

January 31, 2025

Last Updated

March 10, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations

GB(1)